SLR Investment Corp. Q1 2021 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2021. SLR Investment Corp. is a closed-end, externally managed business development company (BDC) regulated under the Investment Company Act of 1940. The Company invests primarily in leveraged middle-market companies through senior secured loans, stretch-senior loans, financing leases, and equity securities. As of the period end, the portfolio consisted of 105 portfolio companies.
Key Financial Metrics
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Net Investment Income | $15.5 million | $15.9 million |
| Net Realized Gain (Loss) | ($0.4) million | $0.03 million |
| Net Change in Unrealized Gain (Loss) | $6.4 million | ($91.4) million |
| Net Increase in Net Assets from Operations | $21.5 million | ($75.5) million |
| Earnings Per Share (Basic & Diluted) | $0.51 | ($1.79) |
| Total Net Assets | $856.2 million | $813.1 million |
| Net Asset Value (NAV) Per Share | $20.26 | $19.24 |
| Total Debt (Face Amount) | $711.0 million | $677.0 million |
| Cash and Cash Equivalents | $357.8 million | $485.5 million |
| Asset Coverage Ratio | 220.4% | 225.9% |
Material Changes vs. Prior Period
- Operational Performance: The Company reported a significant turnaround from Q1 2020, shifting from a net decrease in net assets of $75.5 million to a net increase of $21.5 million. This improvement was driven primarily by a $6.4 million net unrealized gain, reversing the $91.4 million unrealized loss recorded in the prior year.
- Investment Activity: The Company invested approximately $98.7 million across 15 portfolio companies, compared to $79.6 million in Q1 2020. Proceeds from dispositions totaled $65.5 million, a decrease from $197.5 million in the prior year.
- Debt Levels: Total debt face amount increased to $711.0 million from $677.0 million, reflecting increased borrowing to fund new investments. The Credit Facility borrowings increased to $235.0 million.
- Portfolio Composition: The portfolio allocation shifted slightly, with Life Science senior secured loans increasing to 21.2% of the portfolio (from 22.4% in Q1 2020) and Asset-Based loans decreasing to 25.8% (from 31.8%).
Guidance, Outlook, and Risks
- Distributions: On May 5, 2021, the Board declared a quarterly distribution of $0.41 per share, payable July 2, 2021. The Company intends to maintain its status as a Regulated Investment Company (RIC) by distributing at least 90% of taxable income.
- LIBOR Transition Risk: The filing highlights significant risk regarding the phase-out of the London Interbank Offered Rate (LIBOR). The Company notes that many portfolio loans and credit facilities are LIBOR-based. The transition to alternative rates (e.g., SOFR) may require renegotiation of terms and could adversely affect interest income or borrowing costs.
- Market Risk: The Company remains exposed to interest rate volatility. A hypothetical 1% increase in LIBOR would decrease net investment income by approximately $0.05 per share, while a 1% decrease would increase it by $0.02 per share.
- Valuation: The majority of the portfolio (Level 3 assets) relies on unobservable inputs. Management utilizes a multi-step valuation process involving independent third-party firms to determine fair value.
Investor Verification Checklist
- Debt Covenants: Verify continued compliance with asset coverage ratios (currently 220.4%) and other financial covenants under the Credit Facility and unsecured notes.
- LIBOR Exposure: Assess the specific impact of the LIBOR phase-out on the Company's floating-rate assets and liabilities, particularly those maturing after 2021.
- Unfunded Commitments: Review the $122.3 million in unfunded commitments to ensure sufficient liquidity exists to meet future funding obligations without diluting shareholders or increasing leverage excessively.
- Non-Qualifying Assets: Monitor the percentage of non-qualifying assets (28.3% of total assets as of March 31, 2021) to ensure the Company remains compliant with the 70% qualifying asset test required under the Investment Company Act of 1940.
- Subsidiary Performance: Review the specific performance of major consolidated subsidiaries (SLR Credit Solutions, SLR Equipment Finance, Kingsbridge Holdings) as they represent significant portions of the portfolio and income.